FR2146437B1 - - Google Patents

Info

Publication number
FR2146437B1
FR2146437B1 FR7226238A FR7226238A FR2146437B1 FR 2146437 B1 FR2146437 B1 FR 2146437B1 FR 7226238 A FR7226238 A FR 7226238A FR 7226238 A FR7226238 A FR 7226238A FR 2146437 B1 FR2146437 B1 FR 2146437B1
Authority
FR
France
Prior art keywords
aggregatess
conditin
coprecipitated
lungs
aggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7226238A
Other languages
English (en)
Other versions
FR2146437A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2146437A1 publication Critical patent/FR2146437A1/fr
Application granted granted Critical
Publication of FR2146437B1 publication Critical patent/FR2146437B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
FR7226238A 1971-07-20 1972-07-20 Expired FR2146437B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16445671A 1971-07-20 1971-07-20
US265849A US3872226A (en) 1971-07-20 1972-06-23 Tc{14 99m albumin aggregates with stannous tin and denatured albumin

Publications (2)

Publication Number Publication Date
FR2146437A1 FR2146437A1 (fr) 1973-03-02
FR2146437B1 true FR2146437B1 (fr) 1976-07-02

Family

ID=26860576

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7226238A Expired FR2146437B1 (fr) 1971-07-20 1972-07-20

Country Status (9)

Country Link
US (1) US3872226A (fr)
BE (1) BE786566A (fr)
CA (1) CA1011653A (fr)
CH (1) CH563776A5 (fr)
DE (1) DE2235681A1 (fr)
FR (1) FR2146437B1 (fr)
IT (1) IT1048987B (fr)
NL (1) NL178130C (fr)
SE (1) SE417896B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1389809A (en) * 1972-06-05 1975-04-09 Medi Physics Inc 99m-technetium labeled macroaggregated human serum albumin pharmaceutical
US4024233A (en) * 1972-06-05 1977-05-17 Medi-Physics, Inc. 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
FR2281134A1 (fr) * 1974-08-06 1976-03-05 Commissariat Energie Atomique Procede de marquage au 99m technetium
US4042677A (en) * 1974-08-29 1977-08-16 Union Carbide Corporation Technetium-99m labeled radiodiagnostic agents and method of preparation
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
GB1534956A (en) * 1975-05-15 1978-12-06 Ermans A Method of labeling proteins with technetium
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
GB1535847A (en) * 1976-03-19 1978-12-13 Radiochemical Centre Ltd Technetium-99m labelled tin colloid for body scanning
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
US4187285A (en) * 1977-12-16 1980-02-05 E. R. Squibb & Sons, Inc. Microaggregated albumin
US4424200A (en) 1979-05-14 1984-01-03 Nuc Med Inc. Method for radiolabeling proteins with technetium-99m
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
CH652599A5 (de) * 1981-08-28 1985-11-29 Solco Basel Ag Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung.
US5208007A (en) * 1988-11-22 1993-05-04 Board Of Regents Of The University Of Oklahoma Isotopic tracer composition and method for making and using same
US6730286B2 (en) 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
US8551162B2 (en) * 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling

Also Published As

Publication number Publication date
CH563776A5 (fr) 1975-07-15
NL178130B (nl) 1985-09-02
FR2146437A1 (fr) 1973-03-02
CA1011653A (en) 1977-06-07
DE2235681A1 (de) 1973-02-08
IT1048987B (it) 1980-12-20
NL7210027A (fr) 1973-01-23
BE786566A (fr) 1973-01-22
SE417896B (sv) 1981-04-27
US3872226A (en) 1975-03-18
NL178130C (nl) 1986-02-03

Similar Documents

Publication Publication Date Title
FR2146437B1 (fr)
SE394078B (sv) Hjertventilprotes.
IL43522A0 (en) Thermosetting compositions based on epoxyresins and processes for the preparation thereof
IT974016B (it) Perfezionamento nei cannelli di saldatura
CA947992A (en) Ball joint
GB1374884A (en) Whole protein shampoo composition
Skinner Catullus 8: The Comic" Amator" as" Eiron"
FI46026C (fi) Pyörätuoli, jota voidaan käyttää portaissa.
IT1051609B (it) Originali isopropil 2 tetraidro ossazine 1.3 sostituite,loro procedimento di preparazione e loro applicazione in terapia
IT957983B (it) Perfezionamento nei recipienti nebulizzatori
ES173420Y (es) Pieza de union para aparatos de anestesia y dispositivos derespiracion.
SE418962B (sv) Kompositkropp samt forfarande for framstellning av kompositkroppen
BE782124A (fr) Perfectionnements aux ou concernant les projecteurs correcteursde niveaux
Schoder Vergil's Poetic Use of the Cumae Area
IE36289B1 (en) 2,4 - diamino-5-benzylpyrimidines and preparations thereof
IT1051602B (it) Ossazin,5,6,e,indoli sostituiti,loro procedimento di preparazione e loro applicazione in terapia
Miller Sr West German foreign policy: the turn to the East
IT1012046B (it) Perfezionamenti nei freni
森下光夫 Joseph L. Sutton: Territorial Claims of Russia and Japan in the Kurile Island, No. 1, 1951, 34-61
Milne Need structure, professional orientation and mobility
FI45723C (fi) Sangan nivel.
Smith Torah in the Messianic Age and/or the Age to Come
IT947660B (it) Procedimento e apparecchio per montare la parte anteriore
AU450881B2 (en) Improvements in or relating to sockets for ball and socket joints
Barbopoulos Recoilless fraction of gammas in tin dioxide (Sn02)